Navigation Links
Mindray Medical Announces Participation in Upcoming Investor Conferences
Date:11/8/2010

SHENZHEN, China, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will participate in the following conferences:

  • Morgan Stanley Ninth Annual Asia Pacific Summit, to be held November 9-11, 2010 at the Mandarin Oriental in Singapore. Participants from Mindray will be Mr. Xiting Li, President and Co-CEO and Ms. May Li, Director and Head of Investor Relations. Management is scheduled to present at 2:15 pm on Thursday, November 11, and will meet with investors throughout the day.
  • 2010 Credit Suisse Asian Healthcare Conference, to be held November 16-17, 2010 at the Conrad Hotel in Hong Kong. The conference will be attended by Ms. May Li, Director and Head of Investor Relations of Mindray. Ms. Li is scheduled to present at 9:00 am on Tuesday, November 16 and will meet with investors throughout the two-day conference.
  • Daiwa Investment Conference (Hong Kong), to be held November 16-19, 2010 at the Island Shangri-La in Hong Kong. The conference will be attended by Ms. May Li, Director and Head of Investor Relations of Mindray. Ms. Li will meet with investors on November 19.
  • Piper Jaffray 22nd Annual Healthcare Conference, to be held November 30 - December 1, 2010 at the New York Palace Hotel in New York. The conference will be attended by Mr. Ronald Ede, Chief Financial Officer of Mindray. Mr. Ede is scheduled to present at 8:30 am EST on Tuesday, November 30 and will meet with investors throughout the morning.

  • About MindrayWe are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.For further information, please contact:  In the U.S.:Hoki LukWestern Bridge, LLCTel:   +1-646-808-9150Email: hoki.luk@westernbridgegroup.comIn China:Cathy GaoMindray Medical International LimitedTel:   +86-755-2658-2620Email: cathy.gao@mindray.com
    '/>"/>

    SOURCE Mindray Medical International Limited
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
    2. Mindray Medical to Present at J.P. Morgan China Conference 2010
    3. Mindray Medical Provides Mid-Year Update on Product Development
    4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
    5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
    6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
    7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
    8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
    9. /C O R R E C T I O N - Mindray Medical International Limited /
    10. Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
    11. Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
    (Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
    (Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
    Breaking Medicine Technology:
    (Date:4/25/2017)... ... April 25, 2017 , ... ... California, committed to raising awareness for Duchenne muscular dystrophy, and funding for ... CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. ...
    (Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
    (Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... The doctors ... Richmond, BC, who live with dental fear and require sedation to receive dental care. ... at ease during various procedures, from hygienic cleanings to oral surgery, at their dental ...
    (Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
    (Date:4/25/2017)... ... 25, 2017 , ... As Spring reignites vigilance against Zika ... to Zika virus during pregnancy, as well as other prenatal exposures like cocaine, ... , The Teratology Society is an international and multidisciplinary group of ...
    Breaking Medicine News(10 mins):